四头肌收缩疲劳是否会影响COPD慢性呼吸衰竭患者的康复结果?
Mara Paneroni1, Beatrice Salvi1, Carla Simonelli1
1Respiratory Rehabilitation Unit, Istituti Clinici Scientifici Maugeri IRCCS, Institute of Lumezzane, Brescia, Italy.
ERJ open research
|September 10, 2025
概括
四头肌的外周肌肉疲劳 (pMF) 预测慢性呼吸衰竭患者在接受肺部康复的COPD患者的炼结果更好. 这一发现表明pMF可以优化培训协议以获得更好的结果.
科学领域:
- 肺部医学 肺部医学
- 运动生理学 运动生理学
- 呼吸系统康复 呼吸系统康复
背景情况:
- 四头肌的外周肌肉疲劳 (pMF) 影响中度慢性肺炎的运动反应.
- 这项研究研究了pMF在患有慢性呼吸衰竭 (COPD-CRF) 的严重COPD患者的预测作用.
研究的目的:
- 调查四肢体pMF在预测COPD-CRF患者肺部康复结果中的作用.
- 为了确定基线pMF是否影响康复后运动能力和生活质量的改善.
主要方法:
- 对30名COPD-CRF患者进行后期分析,这些患者接受了20次耐力训练.
- 通过电神经刺激和测量6分钟步行测试 (6MWT),疲劳严重程度尺度 (FSS) 和康复前后的生活质量来评估四头肌pMF.
主要成果:
- 12名患者 (40%) 具有基线pMF,显示较低的6MWD和较高的FSS.
- pMF组在6MWD康复后 (71.67m与35.28m) 显示出明显更大的改善.
- 基线pMF预测在6MWD (OR 6.25) 中超过临床重要的最小差异的可能性更高.
结论:
- 基线四头肌pMF是COPD-CRF患者增强6MWT改善的重要预测因素.
- 四肢pMF可能成为优化肺康复策略和预测患者结果的新目标.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
741
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
741
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K


